Haemonetics · 3 days ago
Market Development Manager, Interventional Technologies
Maximize your interview chances
BiotechnologyConsulting
Insider Connection @Haemonetics
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Develop and execute on regional market development business plans in a quarterly quota-based system by implementing market development strategies in targeted accounts.
Gain access and develop the right physician champions in the targeted accounts leveraging corporate resources (e.g. value presentation, economic calculator, advisory boards, and senior executives).
Make key presentations to gain the support of key stakeholders in targeted accounts, including physician leaders/influencers, VP/Executive Service Line Directors, VP/Directors of Supply Chain Management, and C-Suite staff.
Develop KOL advocates to educate and influence key stakeholders outside of their own accounts regionally and even nationally.
Support Corporate Accounts contract discussions with hospital and IDN leadership as required to gain account access, ensuring Cardiva meets or exceeds both ASP and revenue growth goals.
Collaborate with the field team to coordinate account activities so the company acts as one integrated team.
Accountable for compliance with Company policy and procedures, the Quality System and other regulatory requirements.
Maintains company standards involving ethical and moral character, and always represents the company with the highest professional standards.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
History of developing the right physician champions for a novel medical technology, repeated success gaining approval from hospital and IDN Value Assessment Committees (VACs), influencing hospital leadership to adopt a new technology.
Adept and experienced at creating and leveraging resources, including presentations, clinical data, healthcare economic models & calculator, advisory boards, etc.
Demonstrated success creating and implementing new strategies, measuring results and adapting approach until success is achieved.
Action-oriented leader who possesses a great sense of urgency and strong work ethic.
Possess an advanced Emotional Quotient (EQ) to thrive in a rigorous, demanding, fast-paced environment, possessing resiliency to bounce back to try an alternative approach until meeting or exceeding expectations.
Ability to build partnerships within the company to meet or exceed jointly owned objectives.
Demonstrated ability to establish personal credibility in the targeted territory to create a forum for delivering our message to clinical staff, administrators, and physicians as well as overcoming obstacles.
Demonstrated consultative selling skills in a complex sales cycle in the medical field. Must have a history of success selling to multiple stakeholders, including physician leaders, service line VPs/executive directors, IDN leaders, and C-Suite personnel.
Proven business acumen with the ability to utilize clinical data, business analytics, targeting & prioritizing key accounts along with stakeholders.
Successful history of following and developing best practices while adapting as necessary to accomplish commercial objectives.
Accountable for compliance with Company policy and procedures, the Quality System and other regulatory requirements.
Maintains company standards involving ethical and moral character, and always represents the company with the highest professional standards.
Preferred
BA/BS or equivalent experience preferred
A minimum of 8+ years of related experience in medical sales, market development, HealthCare Economics & Outcomes Research (HCEOR) is preferred.
MBA or MHA preferred
Company
Haemonetics
Haemonetics is a provider of blood and plasma supplies and services.
Funding
Current Stage
Public CompanyTotal Funding
$1.75B2024-05-21Post Ipo Debt· $600M
2021-03-01Post Ipo Equity· $435M
2019-05-23Post Ipo Equity· $10M
Leadership Team
Recent News
2024-11-09
Morningstar, Inc.
2024-11-07
2024-06-05
Company data provided by crunchbase